Gene Query: GOLM1

Dataset Description Geneva Score
Genome wide expression change in LCC2 and MCF-7 cells 155.01
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 76.13
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 76.13
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 57.31
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 47.45
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 47.45
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 46.36
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 43.46
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 43.42
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 39.18
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 39.18
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 39.06
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 37.22
Zika infected neural stem cells 36.91
Transcriptome analysis of Zika infected neural stem cells 36.91
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 35.05
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 34.7
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 33.98
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 33.65
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 33.65
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 33.35
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 33.35
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 32.34
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 32.16
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 31.96
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 31.96
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 31.95
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 31.95
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 31.77
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 31.59
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 31.59
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 30.94
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 30.85
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 30.76
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 30.54
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 30.54
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 30.25
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 30.2
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 29.33
Downregulation of DDX5/DDX17 and REST 29.11
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 28.93
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 28.66
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 28.6
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 28.44
Control of prostate tumour growth by the long non-coding RNA GHSROS 27.69
Patient-derived luminal breast cancer xenografts with progestins 27.52
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 27.52
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 27.39
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 27.23
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 27.23
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 27.09
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 27.0
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 26.97
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 26.97
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 25.73
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 25.73
ChIP-seq and RNA-seq from human lymphoma cell lines 25.62
RNA-seq data from human lymphoma cell lines 25.62
The Genomic Landscape of Atypical Fibroxanthoma 25.57
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 25.49
RNA-seq analysis of AML cells in response to ASLAN003 25.46
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 25.37
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 25.33
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 25.2
RNA-sequencing of human liver tissue 25.14
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 25.02
RNA-seq analyses of human prostate cancer cells 24.68
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 24.01
Targeting EZH2 in MYCN-amplified Neuroblastoma 24.01
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 23.79
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 23.59
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 23.59
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 23.12
Spliceosomal disruption of the non-canonical BAF complex in cancer 22.8
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 22.66
STRIPAK directs PP2A activity to promote oncogenic transformation 22.38
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 22.18
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 22.1
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 21.9
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 21.9
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 21.62
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 21.62
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 21.62
Fbxo32 mediated gene expression program underlies EMT and metastasis 21.51
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 21.43
Gene expression changes associated with resistance to tagraxofusp (SL-401) 21.2
RNA-seq analysis to identify the genes regulated by p53-SET interplay 21.0
Human embryonic stem cells in E8 and AKIT culture medium 20.92
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 20.92
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 20.71
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 20.71
Cleavage Factor Im as a key regulator of 3’ UTR length 20.57
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 20.39
Developmental stage specific chromosome architecture in human erythroid cells 20.39
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 19.9
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 19.9
Uridylation by TUT4 and TUT7 marks mRNA for degradation 19.77
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 19.74
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 19.6
Global analysis of alternative splicing regulated by RBM10 19.56
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 19.56
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 19.44
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 19.12
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 18.9
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 18.9
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 18.89
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 18.81
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 18.68
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 18.49
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 18.36
A map of gene expression in neutrophil-like cell lines 18.31
Differetially expressed genes after hTR overexpression in U2OS cells 18.17
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 17.93
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 17.93
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 17.8
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 17.8
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 17.75
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 17.67
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 17.59
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 17.5
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 17.36
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 17.26
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 17.09
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 17.05
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 17.02
Gene Expression Profiling of SPOP Knocked Down Cell 17.0
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 16.97
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 16.93
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 16.79
Non-coding regions are the main source of tumor-specific antigens [human] 16.76
Non-coding regions are the main source of tumor-specific antigens 16.76
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 16.6
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 16.58
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 16.41
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 16.17
RIG-I and MDA5 fRIP during KSHV lytic reactivation 16.05
NRDE2 negatively regulates nuclear exosome functions 15.99
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 15.78
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 15.76
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 15.64
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 15.64
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 15.56
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 15.51
Transcriptome analysis of human lung epithelial cells 15.34
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 15.34
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 15.15
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 15.15
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 15.15
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 15.02
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 14.94
Effect of disulfiram treatment on pediatric high grade glioma 14.85
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 14.81
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 14.8
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 14.64
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 14.48
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 14.47
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 14.45
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 14.4
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 14.38
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 14.17
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 14.14
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 14.05
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 14.05
3’ Uridylation Expands miRNA Target Repertoire 13.96
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 13.84
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 13.77
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 13.72
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 13.72
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 13.72
Gene expression analysis of human liver progenitor-like cells in culture 13.64
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 13.49
Gene expression analysis of the impact of TDP-43 knockout in human cells. 13.47
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 13.42
High-Throughput Kinetic Analysis of Fractional Killing 13.38
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 13.36
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 13.28
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 13.27
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 12.99
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 12.94
Expression profiling of etoposide-induced senescent cells 12.85
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 12.81
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 12.77
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 12.76
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 12.76
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 12.76
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 12.76
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 12.72
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 12.72
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 12.71
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 12.71
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 12.64
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 12.64
RNA-seq of cells with TET1 knockout 12.61
Gene profiling of human adult and pediatric liver cancer cells 12.49
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 12.44
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 12.44
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 12.43
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 12.36
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 12.35
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 12.33
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 12.28
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 12.24
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 12.21
Mitochondrial dsRNA triggers antiviral signalling in humans 12.19
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 12.19
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 12.12
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 12.11
Transcriptome-wide identification of CELF2 functional targets in T cells 12.09
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 12.07
SRSF2 mutations impair hematopoiesis and alter exon recognition 12.05
RNA-seq analysis of differentiating human erythroblasts 12.02
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 11.91
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 11.9
Transcriptome analysis in Neobractatin treated cells 11.86
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 11.82
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 11.82
Systematic discovery of endogenous human ribonucleoprotein complexes 11.81
Gene expression profiling of KSHV-infected periodontal ligament cells 11.78
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 11.57
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 11.52
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 11.45
MEIS1 regulates hematopoiesis in hPSCs 11.39
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 11.39
Survival of pancreatic cancer cells lacking KRAS function 11.36
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 11.35
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 11.3
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 11.29
Functional role of CPPED1 in trophoblasts. 11.27
A prostate cancer chromatin interaction map 11.26
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 11.25
RNA-sequencing of human tendon after injury 11.24
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 11.23
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 11.23
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 11.23
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 11.21
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 11.21
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 11.11
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 11.11
Accurate annotation of human protein-coding small open reading frames 11.08
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 10.92
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 10.88
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 10.87
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 10.85
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 10.85
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 10.78
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 10.78
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 10.77
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 10.75
RNA-seq of stable and unstable section of human atherosclerotic plaques 10.74
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 10.62
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 10.59
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 10.56
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 10.55
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 10.51
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 10.48
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 10.46
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 10.41
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 10.36
Retinoic acid suppresses MYB in adenoid cystic carcinoma 10.36
Transcriptome analysis of virus infected tissues 10.34
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 10.25
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 10.21
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 10.21
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 10.1
RNA-seq of naive and primed ES cells 10.08
SNHG5 siRNA knock down in HCT116 cells 10.05
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 10.03
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 10.02
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 9.99
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 9.99
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 9.96
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 9.89
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 9.74
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 9.71
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 9.67
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 9.63
Expression profiling of MCF-7 cells with treatment of TCDD 9.63
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 9.62
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 9.57
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 9.56
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 9.52
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 9.38
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 9.21
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 9.17
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 9.17
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 9.1
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 9.01
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 8.95
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 8.94
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 8.92
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 8.87
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 8.87
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 8.84
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 8.84
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 8.75
Identifying the molecular mode of action of itraconazole in colorectal cancer 8.74
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 8.73
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 8.62
Postnatal lipids drive hepatocyte maturation 8.62
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 8.57
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 8.52
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 8.5
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 8.45
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 8.45
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.41
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 8.38
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 8.35
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 8.32
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 8.28
Integrin signaling regulates YAP/TAZ to control skin homeostasis 8.28
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 8.27
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 8.16
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 8.05
A549 cells and MSR-A549 cells 8.05
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 8.04
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 7.97
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 7.86
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 7.85
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 7.85
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 7.79
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 7.79
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 7.74
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 7.74
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 7.57
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 7.57
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 7.55
RNA-Seq analysis of breast cancer cells after shikonin treatment 7.53
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 7.47
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 7.47
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 7.45
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 7.45
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 7.44
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 7.42
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 7.19
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 7.18
RNA transcriptome analysis during HSV-1 infection 7.16
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 7.03
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 6.88
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 6.82
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 6.78
Reprogrammed myeloid cell transcriptomes in NSCLC 6.77
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 6.76
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 6.76
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 6.75
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 6.69
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 6.57
Fibroblasts in cholesteatoma activate osteoclasts. 6.49
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 6.4
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 6.4
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 6.38
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 6.14
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 6.0
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 5.99
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 5.93
Molecular Criteria for Defining the Naive Human Pluripotent State 5.91
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 5.9
Single cell transcriptome of peritoneal cells 5.9
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 5.75
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 5.75
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 5.72
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 5.68
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 5.67
Effect of ILF3 on translation during homeostasis and the antiviral response 5.62
MCF-7 as a model for functional analysis of breast cancer risk variants 5.51
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 5.46
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 5.36
Hypoxic transcriptome of SQ20B human head and neck cancer cells 5.35
Searching for target genes of miR-508/509/506/514 in HCT116 cells 5.35
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 5.34
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 5.22
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 5.15
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 5.15
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 5.12
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.08
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 5.04
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.04
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 4.97
Determining mRNA half-lives on a transcriptome-wide scale 4.97
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 4.93
Common inflammatory pathways between NEC and Crohn's disease 4.93
Profiling of escape kinetics of viruses subjected to RNAi 4.93
LIN28A modulates splicing and gene expression programs in breast cancer cells 4.85
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 4.85
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 4.69
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 4.66
JAK dependent survival of ALK- ALCL 4.64
Identification of global XBP1s target gene expression in human prostate cancer cells 4.56
mRNA-sequencing of breast cancer subtypes and normal tissue 4.55
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 4.53
Gene expression profile in breast cancer cell lines using RNA sequencing 4.5
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 4.49
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 4.45
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 4.44
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.44
Gene expression analysis of breast cancer cell-lines 4.42
Gene expression and genome-wide location analysis of breast cancer cell-lines 4.42
miR-93 Targets in Human Endothelial Cells 4.29
Identification of expressed and conserved human non-coding RNAs 4.26
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 4.24
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 4.24
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.22
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 4.17
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 4.07
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 4.05
Transcriptome analysis reveals differential splicing events in IPF lung tissue 3.95
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 3.94
MHC Transcriptomic landscape at haplotype-specific resolution 3.87
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 3.81
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 3.81
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 3.71
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 3.71
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 3.61
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 3.61
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.6
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 3.54
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 3.52
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 3.51
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.46
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 3.33
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 3.23
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 3.23
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 3.18
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 3.1
Repurposing of promoters and enhancers during mammalian evolution 2.96
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.85
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.69
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 2.67
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.66
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 2.65
Fusion discovery in breast cancer cell line 2.59
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.51
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 2.5
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.46
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.42
Changes in human endometrial gland transcriptome over the window of implantation 2.42
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 2.35
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 2.34
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.34
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.3
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.3
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 2.25
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 2.21
Identification of renal resident macrophages across species [C1] 2.19
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 2.15
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 2.08
Enhancer activation during EGF response 2.03
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.03
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.78
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.76
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.68
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.66
Zika virus directly infects human peripheral neurons and induces cell death 1.64
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.64
Transcriptome-wide response to synthetic chromatin protein PcTF 1.61
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.57
Gene expression profile of CRC-derived HILEC 1.55
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.5
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.5
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.46
RNA seq_PDX2_SHP099 1.44
Random mono-allelic expression in MECP2-mutated cells 1.36
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.34
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 1.26
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 1.24
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.21
Modulation of nonsense-mediated decay by rapamycin 1.18
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 1.13
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 1.13
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.11
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 1.05
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 1.05
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 1.03
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.01
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 0.97
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.78
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.76
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.64
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.53
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.52
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.49
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.49
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 0.44
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.43
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.41
Identification of the role of polydom in neurofibromas 0.41
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.29
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.27
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.24
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 0.23
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.19
Transcriptome of Stabilin-1 siRNA transfected human monocytes 0.19
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.18
SOX11 knockdown in B-ALL cell lines 0.11
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 0.09
RNA-seq analysis and shRNA screen of breast cancer 0.07
RNA-seq analysis of breast cancer 0.07
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.05
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.02
MYCi975 regulates MYC target genes 0.02
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation